Hypertension Diagnostics, Inc. (HDII)

Market Cap	285.00
Revenue (ttm)	3.79M +88.9%
Net Income	-125.39K
EPS	-0.00
Shares Out	284.78M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,000
Open	0.000001
Previous Close	0.000001
Day's Range	0.000001 - 0.000001
52-Week Range	0.000001 - 0.0002
Beta	-30.44
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Hypertension Diagnostics

Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marker of cardiovascular disease. The company offers CVProfilor DO-2020, which provides a patient’s arterial elasticity indices used in the assessment for u...

• Industry: Shell Companies
• Sector: Financials
• Founded: 1988
• Employees: 3
• Stock Exchange: OTCMKTS
• Ticker Symbol: HDII

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 16, 2026

Data Sources Report a data error